Location: Cambridge, MA
CIK: 0001400240 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value: $2.376B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna Inc | 12,886,743 | $1.524B | 64.1% | $16.43 | +823.3% | COM | 60770K107 |
| SANA | Sana Biotechnology Inc | 34,239,018 | $205M | 8.6% | $32.56 | -77.8% | COM | 799566104 |
| — | Seres Therapeutics Inc | 23,117,045 | $148M | 6.2% | $7.75 | — | COM | 81750R102 |
| — | Omega Therapeutics Inc | 25,902,269 | $140M | 5.9% | $18.85 | — | COM | 68217N105 |
| FHTX | Foghorn Therapeutics Inc | 12,674,120 | $109M | 4.6% | $19.16 | -32.8% | COM | 344174107 |
| — | Evelo Biosciences Inc | 50,427,328 | $105M | 4.4% | $5.89 | — | COM | 299734103 |
| DNLI | Denali Therapeutics Inc | 2,619,968 | $80.41M | 3.4% | $17.97 | +80.9% | COM | 24823R105 |
| — | Axcella Health Inc | 18,867,785 | $32.26M | 1.4% | $6.29 | — | COM | 05454B105 |
| — | Rubius Therapeutics Inc | 38,506,526 | $16.56M | 0.7% | $24.00 | — | COM | 78116T103 |
| SYRS | Syros Pharmaceuticals Inc | 993,848 | $6.4M | 0.3% | $8.12 | 0.0% | COM | 87184Q206 |
| — | Sigilon Therapeutics Inc | 10,370,369 | $5.185M | 0.2% | $48.03 | — | COM | 82657L107 |
| — | Codiak Biosciences Inc | 3,540,636 | $2.762M | 0.1% | $23.99 | — | COM | 192010106 |